{"retracted":false,"update":{"timestamp":1488326400000,"doi":"10.1158/1078-0432.ccr-16-3089","type":"correction"},"doi":"10.1158/1078-0432.ccr-15-2724","journal":"Clinical Cancer Research","publisher":"American Association for Cancer Research (AACR)","title":"Correction: PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitorâ€“Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation"}
